Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
Clinical trial NCT04294251 · COMPLETED
Trial details
- NCT number
- NCT04294251
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-04
- Primary completion
- 2021-01-07
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.